Literature DB >> 35832287

Analytical and Computational Modeling of Sustained-Release Drug Implants in the Vitreous Humor.

Anahid Khoobyar1, Amin Naghdloo1, Anita N Penkova2, Mark S Humayun3, Satwindar Singh Sadhal4.   

Abstract

Sustained ocular drug delivery systems are necessary for patients needing regular drug therapy since frequent injection is painful, undesirable, and risky. One type of sustained-release systems includes pellets loaded with the drug, encapsulated in a porous shell that can be injected into the vitreous humor. There the released drug diffuses while the physiological flow of water provides the convective transport. The fluid flow within the vitreous is described by Darcy's equations for the analytical model and Brinkman flow for the computational analysis while the drug transport is given by the classical convection-diffusion equation. Since the timescale for the drug depletion is quite large, for the analytical model, we consider the exterior surrounding the capsule to be quasi-steady and the interior is time dependent. In the vitreous, the fluid-flow process is relatively slow, and meaningful results can be obtained for small Peclet number whereby a perturbation analysis is possible. For an isolated capsule, with approximately uniform flow in the far field around it, the mass-transfer problem requires singular perturbation with inner and outer matching. The computational model, besides accommodating the ocular geometry, allows for a fully time-dependent mass-concentration solution and also admits moderate Peclet numbers. As expected, the release rate diminishes with time as the drug depletion lowers the driving potential. The predictive results are sufficient general for a range of capsule permeability values and are useful for the design of the sustained-release microspheres as to the requisite permeability for specific drugs.
Copyright © 2021 by ASME.

Entities:  

Year:  2021        PMID: 35832287      PMCID: PMC8597555          DOI: 10.1115/1.4051785

Source DB:  PubMed          Journal:  J Heat Transfer        ISSN: 0022-1481            Impact factor:   1.855


  14 in total

Review 1.  Biodegradable polymers for ocular drug delivery.

Authors:  H Kimura; Y Ogura
Journal:  Ophthalmologica       Date:  2001 May-Jun       Impact factor: 3.250

Review 2.  Biodegradable implants for sustained drug release in the eye.

Authors:  Susan S Lee; Patrick Hughes; Aron D Ross; Michael R Robinson
Journal:  Pharm Res       Date:  2010-06-10       Impact factor: 4.200

Review 3.  Drug delivery from ocular implants.

Authors:  Tsutomu Yasukawa; Yuichiro Ogura; Hideya Kimura; Eiji Sakurai; Yasuhiko Tabata
Journal:  Expert Opin Drug Deliv       Date:  2006-03       Impact factor: 6.648

Review 4.  Intraocular implants for extended drug delivery: therapeutic applications.

Authors:  J L Bourges; C Bloquel; A Thomas; F Froussart; A Bochot; F Azan; R Gurny; D BenEzra; F Behar-Cohen
Journal:  Adv Drug Deliv Rev       Date:  2006-09-22       Impact factor: 15.470

5.  MEASUREMENT OF THE HYDRAULIC CONDUCTIVITY OF THE VITREOUS HUMOR.

Authors:  Anita N Penkova; Shuqi Zhang; Mark S Humayun; Scott Fraser; Rex Moats; Satwindar Singh Sadhal
Journal:  J Porous Media       Date:  2020       Impact factor: 1.663

6.  Biodegradable microspheres for vitreoretinal drug delivery.

Authors:  R Herrero-Vanrell; M F Refojo
Journal:  Adv Drug Deliv Rev       Date:  2001-10-31       Impact factor: 15.470

7.  Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.

Authors:  Silvia Ligório Fialho; Francine Behar-Cohen; Armando Silva-Cunha
Journal:  Eur J Pharm Biopharm       Date:  2007-08-08       Impact factor: 5.571

Review 8.  A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.

Authors:  Yahya E Choonara; Viness Pillay; Michael P Danckwerts; Trevor R Carmichael; Lisa C du Toit
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

Review 9.  Novel drug delivery systems for retinal diseases. A review.

Authors:  Susan S Lee; Michael R Robinson
Journal:  Ophthalmic Res       Date:  2009-03-26       Impact factor: 2.892

10.  Ganciclovir intraocular implant. A clinicopathologic study.

Authors:  N C Charles; G C Steiner
Journal:  Ophthalmology       Date:  1996-03       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.